Cancer clinical trials in the region Bourgogne-Franche-Comté
184 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT06623422
#2023-506327-29-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire de Besançon (Besançon)
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT06252649
#2022-502352-31-00
Adenocarcinoma
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
Targeted therapy
Targeted therapy
Centre hospitalier universitaire François Mitterrand (Dijon)
Amgen
Phase 3
Breast cancer
#NCT06492616
#2024-515445-42-00
HER2 Negative
HR Positive
Localized
None
Hormone therapy
Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon)
Stemline Therapeutics, Inc.
Phase 3
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06819007
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Serous high grade carcinoma (HGSOC)
Endometrioid carcinoma
Clear cell carcinoma
Mucinous carcinoma
Other epithelial ovarian cancer
Stage III
Stage IV
Locally Advanced
Metastatic
HER2
None
Chemotherapy
Targeted therapy
BRCA 1/2
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Daiichi Sankyo